Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin (Q40893088)

24 September 2017

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin (English)

1 reference

24 September 2017

Sidenius N

1

1 reference

PubMed ID

10722842

24 September 2017

Blasi F

series ordinal

2

1 reference

PubMed ID

10722842

24 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 September 2017

1 reference

24 September 2017

470

1 reference

24 September 2017

1

1 reference

24 September 2017

40-46

1 reference

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Regulation of integrin function by the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Integrin activation by R-ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Bcr/Abl expression stimulates integrin function in hematopoietic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Cell-surface acceleration of urokinase-catalyzed receptor cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901282-5

10.1016/S0014-5793(00)01282-5

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

10722842